Envista Holdings Corp (NVST) Stock Price, Financials & Summary

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$23.34

From 52W high−22.84%

Volume5.63M

Market cap$3.75B

P/E (TTM)39.6x

P/S (TTM)1.3x

Div yield—

Key dataSep 18, 2026

Open

$23.34

From 52W high

−22.84%

Volume

5.63M

Market cap

$3.75B

ValuationView details →

P/E (Fwd)

14.8x

EV/EBITDA

10.7x

P/E (TTM)

39.6x

RSI (14)

26.1

MomentumView details →

1D Return

−1.44%

YTD Return

+7.76%

SummaryUpdated Jul 1, 2026

Envista Holdings Corp (NYSE:NVST) is a dental products company that was spun off from Danaher Corporation in September 2019. The company manufactures and markets a comprehensive portfolio of dental equipment, consumables, and specialty products used by dental professionals worldwide. Based in Brea, California, Envista employs approximately 12,800 people and operates through two primary business segments serving the global dental care market. The company has faced significant challenges in recent years, including a major goodwill impairment in 2024, but continues to focus on growth investments in key areas like clear aligners and dental implants.

Ask drillr about Envista Holdings Corp →

ValuationView details →

P/E (Fwd)

14.8x

P/E (TTM)

39.6x

EV/EBITDA

10.7x

EV/Sales

1.3x

P/S (TTM)

1.3x

P/B (TTM)

—

ProfitabilityView details →

Gross Margin

55.50%

Net Margin

3.33%

EBITDA Margin

12.30%

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

1.02x

GrowthView details →

Revenue YoY

+11.89%

EPS YoY

+87.54%

FCF YoY

−9.93%

Revenue CAGR 3Y

+1.91%

EPS CAGR 3Y

−42.33%

EBITDA YoY

+20.23%

MomentumView details →

1D Return

−1.44%

YTD Return

+7.76%

1Y Return

+11.78%

RSI (14)

26.1

vs 50D SMA

−13.15%

vs 200D SMA

−8.36%

Capital & dividendView details →

Debt/Equity

0.52x

Current Ratio

2.43x

Quick Ratio

2.07x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

$0.41

EPS Surprise

22.28%

Beats (12Q)

8/12

Next Q EPS Est

$0.36

Avg Surprise (4Q)

18.92%

Rev Surprise

2.01%

Financials snapshotView financials →

Revenue (TTM)

2.86B

Net Income (TTM)

95.00M

Op. CF (TTM)

299.30M

Next earningsNov 4, 2026 →

Latest newsMore news →

Paul Keel was appointed Chair of the Board of Envista Holdings Corporation, effective August 19, 2026, while continuing as President and Chief Executive Officer.33d ago

Envista raised its 2026 guidance, citing stronger sales and expanding margins, while noting challenges from China pricing, tariffs, and a tougher fourth quarter.37d ago

Similar companies

Concentra Group Holdings Parent, Inc.CON Hims & Hers Health, Inc.HIMS 艾隆科技688329.SH Brainaurora-b06681.HK Beta Bionics, Inc.BBNX Labcorp Holdings Inc.LH Find similar companies →

Latest newsMore news →

Paul Keel was appointed Chair of the Board of Envista Holdings Corporation, effective August 19, 2026, while continuing as President and Chief Executive Officer.33d ago Envista raised its 2026 guidance, citing stronger sales and expanding margins, while noting challenges from China pricing, tariffs, and a tougher fourth quarter.37d ago Envista Holdings Corporation announced its financial results for the quarter ended July 3, 2026.46d ago